 | Up a level |
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
Vehreschild, J J; Böhme, A; Cornely, O A; Kahl, C; Karthaus, M; Kreuzer, K-A; Maschmeyer, G; Mousset, S; Ossendorf, V; Penack, O; Vehreschild, M J G T; Bohlius, J (2014). Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Annals of oncology, 25(9), pp. 1709-1718. Oxford University Press 10.1093/annonc/mdu035
